Close X

In order to view this PDF document, you must be a registered member of the AsthmaKidCare™ program. To sign up now, please visit the AsthmaKidCare™ registration page.

If you are already a member, simply log in below.

E-mail:
Password:
Sign In

Close X

By listing your child’s date of birth, AsthmaKidCare™ is able to provide you and your child with age-specific information, tips, and resources.

Contact Us

If you would like additional information regarding PULMICORT RESPULES or other AstraZeneca products, please contact the Information Center at AstraZeneca in the United States at 1-800-236-9933, Monday through Friday 8 am to 6 pm ET, excluding holidays.

Enlarge Text:

Print:

E-mail

Password

Welcome

log out | profile

Indication and Important Safety Information

PULMICORT RESPULES is developed and approved specifically for children 12 months to 8 years of age, to help prevent asthma symptoms that could lead to an attack.

PULMICORT RESPULES, an inhaled corticosteroid, is not a quick-relief medication and should NOT be used to treat an acute asthma attack. In studies, side effects included respiratory infection, runny nose, earache, and coughing. Inhaled corticosteroids may cause a reduction in growth rate. The long-term effect on final adult height is unknown. If switching to PULMICORT RESPULES from an oral (syrup or pill) corticosteroid, follow the doctor's instructions to help avoid health risks. Tell the doctor if your child is exposed to chicken pox or measles.

Talk to your doctor about PULMICORT RESPULES.

Read the full Prescribing Information (PDF – 242KB)

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.FDA.gov/medwatch or call 1-800-FDA-1088.

Site Map | Contact Us | Prescription Assistance Programs